Post-Traumatic Stress Disorder Treatment Market Research, 2031
The global Post Traumatic Stress Disorder Treatment Market size was valued at $16.0 billion in 2021 and is projected to reach $26.1 billion by 2031, growing at a CAGR of 4.9% from 2022 to 2031. Post-traumatic stress disorder is a mental disorder that one can develop after exposure to a traumatic event, such as sexual assault, warfare, traffic collisions, child abuse, or other threats to a person's life. It is a mental disorder characterized by disturbing symptoms that interfere with daily functioning. Symptoms of post-traumatic stress disorder may start quickly following a traumatic event or they might not appear for years after the event including intrusive memories or reliving of the experience, avoidance of anything that reminds the person of the trauma, negative changes in thinking or mood that are a result of the trauma and which interfere with daily functioning, and changes in the persons emotional reactions to everyday events.
Post-traumatic stress disorder (PTSD) is a mental health condition triggered by either experiencing it or witnessing it. Post-traumatic stress disorder treatment help to improve in patients thinking power, changes in physical activity & regain a sense of control over life. The mode of treatment applied for post-traumatic stress disorder includes medication, therapies, self-care & nutrition.
The Post Traumatic Stress Disorder Treatment Market trends are increase in the burden of post-traumatic stress disorder worldwide, a rise in the number of clinical trials pertaining to post-traumatic stress disorder treatment, as well an increase in R&D activities for the introduction of novel therapies and drugs are the key factors that drive thePost Traumatic Stress Disorder Treatment Market growth. For instance, in June 2020, SIU School of Medicine launched a clinical trial to study the safety and efficacy of an investigational drug for post-traumatic stress disorder. Furthermore, in June 2021, ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine stated that the first patient was enrolled in a clinical trial evaluating Nantheia A1002N5S, investigational drug-using cannabidiol in ANANDA proprietary liquid structure delivery technology, as a treatment for post-traumatic stress disorder symptoms and neurocognitive impairment in patients with post-traumatic stress disorder Moreover, increase in R&D activities for antidepressant drugs against post-traumatic stress disorder, rise in government initiatives for post-traumatic stress disorder treatment & management, and increase in healthcare expenditure in developing countries are the key factor that provides Post Traumatic Stress Disorder Treatment Market opportunity for key players operating in market. However, side effects associated with post-traumatic stress disorder treatment and the high cost of the treatment are the major factors that hinder the Post Traumatic Disorder Treatment Market growth.
The Post Traumatic Stress Disorder Treatment Market analysis is done on the basis of treatment type, age group, end-user, and region. On the basis of treatment type, the market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. Psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. On the basis of age group, the market is divided into geriatric, pediatrics, and adults. By end-user, the market is classified into hospitals, outpatients clinics, mental health centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By Treatment Type Segment Review
By treatment type, the Post Traumatic Stress Disorder Treatment market is divided into drugs and psychotherapy. By drugs, the market is classified into antidepressants, antipsychotics, beta-blockers, benzodiazepines, and others. Psychotherapy, the market is divided into cognitive behavior therapy, psychodynamic therapy, and others. The psychotherapy segment holds the Post Traumatic Disorder Treatment Market trends 2021. Owing to the increase in the prevalence of post-traumatic stress disorder and the rise in initiatives by governments for treating their war veterans have also been facilitating the increase in demand for PTSD therapeutics across the world driving the growth of the market.
By Age Group Segment Review
By age group, the Post Traumatic Stress Disorder Treatment Market is divided into geriatric, pediatrics, and adults. The adult segment has the highest Post Traumatic Stress Disorder Treatment Market share in 2021. Owing to a significant rise in violence, cross-border tensions, accidents, and occupational hazards across the world drive the growth of the market.
By End User Segment Review
By end-user, the market is categorized into hospitals, outpatients clinics, mental health centers, and others. The hospital's segment has dominated the market in 2021. owing to an increase in the number of patients visiting in hospital for post-traumatic stress disorder treatment therapy.
By Region Segment Review
North America accounted for a majority of the global Post Traumatic Disorder Industry share in 2020 and is anticipated to remain dominant during the forecast period. This is attributed to the increasing burden of post-traumatic stress disorder, growth in research and development activities as well as the presence of strong and established market players in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to the rise in the geriatric population and the rise in the number of mental and sexual abuse among adults drives the market of growth in this region.
The key players operating in the global Post Traumatic Stress Disorder Industry are Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings Plc, GlaxoSmithKline Plc, Pfizer, Inc, Viatris, Inc, Strategic Behavioral Health, Ascension Seton, North Range Behavioral Health, Pyramid Healthcare and Eily Lilly and Company.
The post traumatic stress disorder treatment market is segmented into Treatment Type, Age Group and End User.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the post-traumatic stress disorder treatment market analysis from 2021 to 2031 to identify the prevailing post-traumatic disorder treatment market opportunities.
- The Market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the post-traumatic stress disorder treatment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global post-traumatic disorder treatment market trends, key players, market segments, application areas, and market growth strategies.
Post-Traumatic Stress Disorder Treatment Market Report Highlights
| Aspects | Details |
 By Treatment Type |
|
 By Age Group |
|
 By End User |
|
 By Region |
|
 Key Market Players | North Range Behavioral Health, Caretech Holdings PLC, Pfizer, Inc, Pyramid Healthcare, Eily Lilly and Company, Behavioral Health Network, Inc, GlaxoSmithKline Plc, Viatris, Inc, Acadia Healthcare, Strategic Behavioral Health |
Analyst Review
According to CXO, the post-traumatic stress disorder treatment market gained prominence in 2021 and is expected to witness a significant rise in the near future. Owing to the increase in cases of post-traumatic stress disorder such as wars, combats, and interpersonal violence, initiatives taken by governments for effective management of stress conditions are the key factor that drives the growth of the market.
Furthermore, the increase in cases of sexual and mental abuse across the world and the rise in the adoption of drugs for the treatment of drugs post-traumatic stress disorder drives the growth of the market. However severe side effects associated with drugs is expected to hamper the market growth. In addition, an increase in initiatives taken by governments for effectively managing post-traumatic stress disorder and rise in healthcare expenditure for mental disorders in developing countries offer lucrative opportunities to the post-traumatic stress disorder treatment market in upcoming years.
Further, North America is expected to witness the highest growth, in terms of revenue, owing to its well-established healthcare infrastructure, the surge in adoption of mental healthcare services, increase in geriatric population, and rise in prevalence of mental diseases.
$15,976.64 million is the industry size of the Post Traumatic Stress Disorder Treatment Market in 2021?
$26,060.75 million is the estimated industry size of the Post Traumatic Stress Disorder Treatment Market in 2031
The upcoming trends in the Post Traumatic Stress Disorder Treatment Market are increase in burden of post-traumatic stress disorder (PTSD) worldwide, a rise in a number of clinical trials pertaining to PTSD treatment as well as increasing research and development of novel therapies and drugs for PTSD are the key factors drive the growth of the market.
North America is the largest regional market for Post Traumatic Stress Disorder Treatment Market
The forecast period in the Post Traumatic Stress Disorder Treatment Market report is from 2021 to 2031
2021 is the base year calculated in the Post Traumatic Stress Disorder Treatment Market.
The Post Traumatic Stress Disorder Treatment Market report does not provide Value Chain Analysis
Acadia Healthcare, Behavioral Health Network, Inc., CareTech Holdings PLC, and GlaxoSmithKline Plc are the top companies to hold the market share in Post Traumatic Disorder Treatment Market.
Loading Table Of Content...
